Last year I linked to a series of perspectives in NEJM with contrasting views on the success or failure of GWAS - David Goldstein's paper and Nick Wade's synopsis that soon followed in the New York Times being particularly pessimistic. Earlier this year I was swayed by an essay in Cell by Jon McClellan and Mary-Claire King condemning the common disease common variant hypothesis and chalking up most GWAS hits to population stratification.